GP5 and neoplasm: Genomic CDH1 alterations with loss of E‐cadherin expression are observed in several tumour types such as lobular mammary, plasmacytoid urothelial, and diffuse gastric carcinoma, and result in pathological morphologies similar to single‐cell GP5 PCa.